COMPANY PROFILE · UPDATED 18 NOV 2025

Revance Therapeutics

Revance Therapeutics, Inc. produces biopharmaceutical products. The Company develops drug delivery and treatments for dermatology and aesthetic medicine. Revance Therapeutics serves patients and doctors throughout the United States.

Newark, NJ

revance.com ↗

Work at Revance Therapeutics? Claim this profile

Healthcare & Biotech Biotech & Drug Discovery Medical Organizations Health Care Companies Biotechnology CompaniesPost Ipo Equity

This is the record ChatGPT, Claude and Google read about Revance Therapeutics. Claiming it controls the source; answers update as assistants re-crawl.

Founded: 2002
Headcount: 128
Open roles: 0
Last raised: Post Ipo Equity

LOCATIONS

Where they work

Revance Therapeutics offices

Newark, NJ

FUNDING

Capital raised

Total raised

$1,679,526,016

Investors

Athyrium Capital Management Bio*One Capital CNF Investments Delphi Ventures EDBI Essex Capital Essex Woodlands Horizon Technology Finance Leader Ventures Medicis Pharmaceutical NovaQuest Capital Management Pac-Link Palo Alto Investors Ramius Shepherd Ventures Technology Partners Vivo Capital

Funding rounds

Post Ipo Equity
$100MMar 3, 2024
Post Ipo Equity
$200MSep 11, 2022
Post Ipo Debt
Athyrium Capital Management
$300MMar 20, 2022
Post Ipo Debt
$250MFeb 11, 2020
Post Ipo Equity
$110.5MDec 3, 2019
Post Ipo Equity
$115MJan 21, 2019
Post Ipo Equity
Ramius
$167.1MDec 10, 2017
Post Ipo Equity
$126MNov 8, 2015
Post Ipo Equity
$131.3MJun 17, 2014
IPO
UndisclosedJan 1, 2014
Series Unknown
$10MOct 23, 2013
Series E
Essex Woodlands, NovaQuest Capital Management, Delphi Ventures
$33MApr 1, 2013
Series D
Essex Woodlands, NovaQuest Capital Management, Technology Partners, Palo Alto Investors, CNF Investments, Shepherd Ventures, Vivo Capital, Pac-Link, Essex Capital
$45MJun 9, 2011
Series D
Essex Woodlands, Technology Partners, Shepherd Ventures, Palo Alto Investors, EDBI, Pac-Link, Vivo Capital, Bio*One Capital
$25.6MDec 27, 2009
Debt Financing
Leader Ventures, Horizon Technology Finance
$8MNov 17, 2008
Series C
Medicis Pharmaceutical, Essex Woodlands, Technology Partners, Shepherd Ventures, Palo Alto Investors, Vivo Capital
$43.2MDec 11, 2007
Series B
Essex Woodlands, Technology Partners, Vivo Capital
$13MApr 26, 2004
Series A
$1.8MMay 26, 2003

Funding data via Diffbot, SEC EDGAR filings and company announcements — a round from a filing or announcement links to it

OPEN ROLES

Roles at Revance Therapeutics

Employbl doesn’t track Revance Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

Hiring team? Claim the profile to keep roles and the careers link accurate

LEADERSHIP